INS and Shock: Compared with the Q1 group, patients in the Q4 group had higher disease severity scores at admission (p < 0.001), higher rates of mechanical ventilation, CRRT treatment, sedative use, vasoactive drug use, and insulin use, as well as higher prevalence of renal disease, liver disease, cardiogenic shock, and septic shock.